Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoprotein. Joshi VR, Newman RM, Pack ML, Power KA, et al. PLoS Pathog 2020;16:e1008577.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Joshi VR, Newman RM, Pack ML, Power KA, et al. Gp41-targeted antibodies restore infectivity of a fusion-deficient HIV-1 envelope glycoprotein. PLoS Pathog 2020;16:e1008577.
PMID: 32392227